awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33401615-E8208DDF-C3E2-482B-8D46-B63790FEAD13
Q33401615-E8208DDF-C3E2-482B-8D46-B63790FEAD13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401615-E8208DDF-C3E2-482B-8D46-B63790FEAD13
Immunomodulatory agents in myelofibrosis.
P2860
Q33401615-E8208DDF-C3E2-482B-8D46-B63790FEAD13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33401615-E8208DDF-C3E2-482B-8D46-B63790FEAD13
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
909862189af5760ab3ec9ea58b4be77bb140733e
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.